Drug Trial Radar · NCT06050915
A Study of DISC-3405 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Dec 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Oct 3, 2023
Primary completion
Jul 9, 2024
Study completion Jul 9, 2024
Sponsor
- Lead sponsor
- Disc Medicine, IncIndustry
- Sponsor type
- Industry
- First posted
- Sep 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This phase 1 study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of DISC-3405 in adult male and female healthy volunteers.
Conditions
- Healthy Volunteer
Interventions
DISC-3405Drug
DISC-3405 is administered as a single dose IV infusion or subcutaneous injection
DISC-3405Drug
DISC-3405 is administered in multiple ascending doses as an IV infusion or subcutaneous injection
PlaceboDrug
Placebo is administered as a single dose IV infusion or subcutaneous injection
PlaceboDrug
Placebo is administered in multiple ascending doses as an IV infusion or subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse eventsTime frame: up to 99 days
- Incidence of treatment-emergent clinically abnormal physical examTime frame: up to 99 days
- Incidence of treatment-emergent clinically significant laboratory test resultsTime frame: up to 99 days
- Incidence of treatment-emergent clinically significant electrocardiograms (ECGs)Time frame: up to 99 days
- Incidence of treatment-emergent clinically abnormal vital signsTime frame: up to 99 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion
Lincoln, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.